Liftstream is an executive search recruitment company in the life sciences sector
Following the publication of our research studies into gender diversity in the biotechnology industry (Diversifying the Outlook – The X&Y of Biotechnology Leadership, Investing in Biotechnology Management), we decided to take the findings of this research and engage with leaders throughout the biotech sector in positive gender-inclusive dialogue. This led to a successful event; Prioritizing Gender Equity, which we constructed collaboratively with partner organisations; Women in Bio and growBOLD. This was a great success with over 100 leaders from across the San Francisco and Bay Area biotech cluster cramming into Genentech’s HQ office to hear some of our top-line data, and even more importantly some great insights from a range of industry leaders.
The trajectory of biotech M&A has been steep in 2015, so the $7.2bn acquisition of Receptos by oncology powerhouse Celgene, increases the gradient even further. This deal came out of left field, especially as commentators were still raking over the sizable partnering deal Celgene has just cemented with Juno Therapeutics in immuno-oncology.
Liftstream has been collaborating with two organisations to put together a key leadership meeting on gender diversity in biotechnology. The event is based on our published research and we have worked with our network of executives to bring about an incredible panel of industry leaders.
Authored by Karl Simpson